{"gene":"TIMP2","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1998,"finding":"TIMP2 binds MT1-MMP (membrane type 1 MMP) primarily through N-terminal domain interactions, leaving the C-terminal domain of MT1-MMP free to interact with progelatinase A (MMP-2). This forms a cell-surface receptor complex that concentrates progelatinase A and potentiates its activation. Residues 568-631 of the progelatinase A C-terminal domain are required for binding to both heparin and TIMP2, and for cell membrane-associated MT1-MMP-dependent activation.","method":"C-terminal domain mutants of MT1-MMP and progelatinase A, soluble MT1-MMP constructs, heparin binding assays, cell membrane preparations from HT1080 cells depleted of endogenous TIMP2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple domain mutants tested in vitro and in cell-based system, reconstitution approach with endogenous TIMP2-depleted membranes, rigorous mutagenesis mapping","pmids":["9422744"],"is_preprint":false},{"year":1998,"finding":"TIMP2 over-expression in B16F10 melanoma cells reduces invasion and angiogenesis but increases resistance to apoptosis while increasing necrosis, demonstrating MMP-inhibition-dependent and MMP-inhibition-independent effects on tumor cell phenotype.","method":"Stable transfection of TIMP2 cDNA into B16F10 cells; in vitro invasion assays; in vivo Matrigel angiogenesis assay; subcutaneous tumor growth in mice; apoptosis/necrosis assays","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss/gain of function with multiple phenotypic readouts in vitro and in vivo, single lab","pmids":["9462715"],"is_preprint":false},{"year":2008,"finding":"TIMP-2 inhibits FGF-2-induced p42/44 MAPK activation and endothelial cell proliferation through binding to integrin α3β1 on endothelial cell surfaces, acting upstream of Shp-1-dependent inhibition of MAPK signaling; dominant-negative Shp-1 and anti-integrin α3/β1 blocking antibodies or siRNA knockdown of integrin α3 abrogated this effect.","method":"Dominant-negative Shp-1 mutant expression; blocking antibodies against integrin α3 and β1; siRNA disruption of integrin α3; protein tyrosine phosphatase inhibitor orthovanadate; MAPK activation assays in human microvascular endothelial cells","journal":"Microvascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal perturbation methods (antibody blocking, siRNA, dominant-negative mutant) converging on same mechanism, single lab","pmids":["18721821"],"is_preprint":false},{"year":2015,"finding":"TIMP-2 binding to MT1-MMP induces rapid and sustained AKT activation in a manner independent of MT1-MMP proteolytic activity but requiring Ras activation; ERK1/2 activation by TIMP-2/MT1-MMP also requires FGFR-1 but AKT activation does not. Both ERK1/2 and AKT activation protect tumor cells from serum starvation-induced apoptosis, while TIMP-2 upregulates apoptosis induced by 3D type I collagen.","method":"Dose- and time-response experiments in MT1-MMP-expressing cells; use of proteolytically inactive MT1-MMP mutants; FGFR-1 inhibition; dominant-negative Ras; apoptosis assays under serum starvation and 3D collagen conditions","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteolysis-dead mutants and multiple signaling inhibitors used, single lab, multiple orthogonal readouts","pmids":["26331622"],"is_preprint":false},{"year":2019,"finding":"TIMP2 functions as a stress-inducible extracellular co-chaperone of HSP90: it binds eHSP90, increases eHSP90 ATPase binding to ATP and inhibits its ATPase activity, disrupts the eHSP90:MMP2 complex to terminally inactivate MMP2, but also loads MMP2 onto eHSP90 in a transient inhibitory state. The activating co-chaperone AHA1 displaces TIMP2 from the complex to reactivate MMP2, forming a molecular switch regulating extracellular proteolysis.","method":"Co-immunoprecipitation; ATP binding and ATPase assays; gene knockout of TIMP2 and AHA1; blocking antibodies against TIMP2 and AHA1 in HT1080 cancer cells; gelatin zymography","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — biochemical reconstitution (ATPase assay), gene KO, blocking antibodies, and zymography, multiple orthogonal methods in one study","pmids":["31412254"],"is_preprint":false},{"year":2014,"finding":"Computational saturation mutagenesis of the TIMP2 MMP-binding interface identified the interface as non-optimal for any single MMP; experimental point mutations produced >10-fold improvement in affinity to MMP14 (MT1-MMP), indicating TIMP2 sequence is a compromise for multispecific binding across 26+ MMP/ADAM family members.","method":"Computational free energy calculations (saturation mutagenesis); experimental surface plasmon resonance binding measurements of TIMP2 point mutants against MMP14","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro binding assay with mutagenesis, computational + experimental validation, single lab","pmids":["24710006"],"is_preprint":false},{"year":2014,"finding":"TIMP2 deficiency (TIMP2−/−) in mice results in enhanced myocardial hypertrophy without fibrosis following angiotensin II infusion, while TIMP3 deficiency produces the inverse (excess fibrosis without hypertrophy), demonstrating that TIMP2 and TIMP3 have distinct and non-redundant roles in cardiac remodeling independent of their shared MMP-inhibitory functions. Reduced collagen cross-linking enzymes LOX and PLOD1 underlie suppressed collagen deposition in TIMP2−/− hearts.","method":"TIMP2−/− and TIMP3−/− mouse models; angiotensin II infusion; echocardiographic imaging; in vitro co-culture of cardiomyocytes with cardiac fibroblasts; collagen cross-linking enzyme measurements","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout models with multiple orthogonal phenotypic readouts (echocardiography, histology, in vitro co-culture, biochemistry), well-controlled","pmids":["24692173"],"is_preprint":false},{"year":2013,"finding":"TIMP2 promotes MMP2 activation in the kidney: ureteral obstruction markedly increased MMP2 activation in TIMP3−/− kidneys but was completely blocked in TIMP2−/− kidneys, demonstrating that TIMP2 is required for pathological pro-MMP2 activation and resultant renal tubulointerstitial fibrosis, while TIMP3 protects from damage.","method":"TIMP2−/− and TIMP3−/− mice; unilateral ureteral obstruction model; gene microarray; collagen I/III expression; MMP2 activation assays; TGF-β/Smad pathway analysis; caspase-3 and TNFR-converting enzyme activities","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO models with multiple biochemical readouts, replicated across TIMP2 and TIMP3 KO for mechanistic contrast","pmids":["23760282"],"is_preprint":false},{"year":2018,"finding":"TIMP2 silencing ameliorates LPS-induced cytokine release and apoptosis in kidney tubular cells via inhibition of the NF-κB pathway (p-P65); kidney-specific TIMP2 knockdown in CLP sepsis mice reduced proinflammatory cytokines and kidney dysfunction, revealing that TIMP2 mediates sepsis-induced AKI through NF-κB regulation.","method":"siRNA knockdown of TIMP2 in HK-2 cells; LPS challenge; cytokine assays; NF-κB (p-P65) western blot; kidney-specific TIMP2 knockdown via lentiviral vector injection; CLP sepsis mouse model; serum creatinine and histopathology","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combined in vitro knockdown and in vivo kidney-specific KD with mechanistic pathway readout, single lab","pmids":["30562560"],"is_preprint":false},{"year":2022,"finding":"TIMP2 interacts with BiP (binding immunoglobulin protein), an ER chaperone, and facilitates its extracellular secretion, thereby triggering ER stress; TIMP2 overexpression induces ER stress while TIMP2 knockdown attenuates LPS-induced ER stress and apoptosis; tubule-specific TIMP2 knockout mice showed decreased ER stress-mediated apoptosis in CLP-induced AKI.","method":"Co-immunoprecipitation of TIMP2 with BiP; TIMP2 overexpression and siRNA knockdown in HK-2 cells; tubule-specific TIMP2 conditional KO mice (Ksp-Cre/TIMP2flox/flox); CLP sepsis model; ER stress markers; serum creatinine; apoptosis assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for physical interaction, conditional KO with phenotypic readout, single lab with multiple orthogonal methods","pmids":["35218571"],"is_preprint":false},{"year":2024,"finding":"Extracellular TIMP2 increases intracellular cAMP, which promotes ubiquitination of NLRP3 via the E3 ligase MARCH7 and subsequent autophagy-dependent NLRP3 degradation, attenuating pyroptosis in renal tubular cells; kidney tubule-specific Timp2 KO mice showed exacerbated pyroptosis (elevated NLRP3, Caspase1, GSDMD) in sepsis-AKI, and exogenous recombinant TIMP2 rescued this.","method":"Kidney tubule-specific Timp2 KO mice; CLP sepsis model; recombinant TIMP2 rescue experiments; LPS-stimulated primary renal tubular cells; cAMP measurement; NLRP3 ubiquitination assays; MARCH7 identification; autophagy flux assays; pyroptosis marker measurement","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO + recombinant protein rescue + mechanistic pathway (cAMP/MARCH7/NLRP3) in single lab with multiple orthogonal methods","pmids":["38497110"],"is_preprint":false},{"year":2023,"finding":"TIMP2 interacts with integrin α3β1 on brain microvascular endothelial cells, inhibiting Src activation-dependent VE-cadherin phosphorylation, VE-cadherin/catenin complex destabilization, and subsequent VE-cadherin internalization; increased membrane localization of VE-cadherin enhances Rac1 activity and inhibits stress fiber formation; an MMP-inhibition-dead mutant (AlaTIMP2) retains these BBB-protective effects, confirming MMP-independent mechanism.","method":"AlaTIMP2 (MMP-inhibitory-dead mutant); TBI mouse model; human brain microvascular endothelial cells under hypoxia/inflammation; mechanistic studies of Src phosphorylation, VE-cadherin internalization/membrane localization, Rac1 activity, and stress fiber formation; integrin α3β1 binding assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — MMP-dead mutant establishes MMP-independence, integrin binding, multiple downstream signaling readouts, in vivo mouse model plus in vitro human cell validation","pmids":["38015626"],"is_preprint":false},{"year":2022,"finding":"Fibroblasts repair blood-brain barrier damage in intracerebral hemorrhage via TIMP2: Col1α1+ fibroblast ablation exacerbated BBB damage, and the protective effect was mediated by TIMP2 through upregulation of tight junction proteins via a paracellular mechanism; exogenous TIMP2 rescued BBB disruption in fibroblast-ablated mice.","method":"Col1α1-targeted fibroblast ablation mice; ICH model; in vitro BBB permeability assays; tight junction protein immunostaining; exogenous TIMP2 rescue experiments; transcytosis-associated protein analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic ablation with exogenous rescue, multiple BBB readouts, single lab","pmids":["36417884"],"is_preprint":false},{"year":2023,"finding":"Neuronal TIMP2 regulates adult hippocampal neurogenesis, dendritic spine turnover, ECM accumulation around synapses, and hippocampus-dependent memory; conditional neuronal TIMP2 knockout mice show increased ECM around synapses, impaired newborn neuron migration through denser ECM, and memory deficits; an Ala-TIMP2 mutant lacking MMP inhibition retains cognitive benefits, indicating MMP-independent mechanism for cognitive effects.","method":"Conditional TIMP2 knockout (neuronal-specific); hippocampus-dependent memory tests; adult neurogenesis and dendritic spine quantification; ECM accumulation imaging; Ala-TIMP2 (MMP-inhibitory-dead) treatment; intraperitoneal injection of TIMP2 and TIMP2-hIgG4 fusion protein in aged mice; cfos expression; synapse density (CA1, DG)","journal":"Molecular psychiatry / eNeuro","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO model, MMP-dead mutant confirming MMP-independence, multiple behavioral and cellular phenotypic readouts, replicated by independent group (Britton et al. eNeuro 2023)","pmids":["37914840","37321845"],"is_preprint":false},{"year":2017,"finding":"The proMMP-2:TIMP-2 complex is endocytosed in rat yolk sac cells by the megalin/LRP-2 endocytic receptor; receptor-associated protein (RAP, a natural LRP antagonist) blocked accumulation of proMMP-2 and TIMP-2; anti-megalin antibodies (but not anti-LRP-1 antibodies) inhibited binding; BIAcore surface plasmon resonance confirmed direct interaction; conditional renal megalin/LRP-2 invalidation in mice caused urinary accumulation of proMMP-2 and TIMP-2.","method":"RAP inhibition; blocking antibodies against megalin/LRP-2 and LRP-1; BIAcore (SPR) direct binding assay; conditional renal megalin/LRP-2 knockout mice; radiolabeled proMMP-2:TIMP-2 uptake assay","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — SPR reconstitution, genetic KO in vivo, blocking antibodies and RAP inhibition, multiple orthogonal methods converging on megalin/LRP-2 as receptor","pmids":["28659595"],"is_preprint":false},{"year":2011,"finding":"TIMP2 transcription in Sertoli cells is activated by the transcription factor CEBPA under basal conditions and repressed by MYC; MEHP (mono-(2-ethylhexyl) phthalate) exposure decreases CEBPA transactivation and increases MYC-mediated repression of the TIMP2 promoter; FSH rescues MEHP-suppressed TIMP2 levels via cAMP-dependent translocation of CEBPA into the nucleus.","method":"Sequential 5'-deletion mutagenesis of the TIMP2 promoter; CEBPA and MYC reporter assays in rat Sertoli cells; FSH and forskolin rescue experiments; CEBPA nuclear translocation assay; actinomycin D experiments","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion mapping, transcription factor identification with rescue experiments, single lab with multiple orthogonal methods","pmids":["21832167"],"is_preprint":false},{"year":2022,"finding":"METTL3-mediated m6A modification of TIMP2 mRNA promotes TIMP2 expression in podocytes in an IGF2BP2-dependent manner; elevated METTL3 in diabetic nephropathy increases m6A on TIMP2 mRNA and modulates Notch signaling to exert pro-inflammatory and pro-apoptotic effects.","method":"METTL3 knockout/overexpression in podocytes; podocyte-conditional METTL3 KO mice; AAV9-shMETTL3 in STZ-diabetic and db/db mice; m6A sequencing/MeRIP; IGF2BP2 identification as m6A reader; Notch signaling pathway readouts","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with m6A sequencing and reader identification, in vivo validation, single lab","pmids":["34995800"],"is_preprint":false},{"year":2017,"finding":"EZH2 represses TIMP2 expression via H3K27me3 and DNA methylation at the TIMP2 promoter in ovarian cancer; EZH2 overexpression promotes MMP2 and MMP9 proteolytic activities and cancer invasion/migration, effects largely reversed by TIMP2 knockdown; EZH2 and H3K27me3 presence at the TIMP2 promoter was confirmed by ChIP.","method":"ChIP for EZH2 and H3K27me3 at TIMP2 promoter; EZH2 overexpression and knockdown; H3K27me3 inhibition; TIMP2 re-expression rescue assays; in vitro invasion/migration; in vivo xenograft","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP validation of promoter occupancy, genetic perturbation with rescue, in vitro and in vivo readouts, single lab","pmids":["28620234"],"is_preprint":false},{"year":2018,"finding":"EZH2-mediated H3K27me3 at the TIMP2 promoter silences TIMP2 transcription in triple-negative breast cancer cells, resulting in increased MMP-2 and MMP-9 activity and enhanced invasiveness.","method":"EZH2 knockdown/overexpression in TNBC cells; MMP-2/-9 activity measurement; invasion assays; TIMP2 promoter methylation analysis","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic perturbation with downstream enzymatic activity readout, consistent with ovarian cancer findings (replicated finding), single lab","pmids":["29636998"],"is_preprint":false},{"year":2014,"finding":"The TIMP2 rs8179096 promoter polymorphism is functional: the T allele shows 2.5-fold increased promoter activity compared to the C allele; both alleles bind nuclear factor kappa B (NF-κB), suggesting NF-κB as a transcriptional regulator of TIMP2.","method":"Promoter-reporter luciferase assays; DNA-protein binding (EMSA) for NF-κB","journal":"Journal of dental research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter activity assay plus DNA-protein binding assay for specific transcription factor, single lab","pmids":["24799419"],"is_preprint":false},{"year":2010,"finding":"Hypoxia reduces TIMP-2 secretion from human monocytes and endothelial cells by inhibiting TIMP-2 transcription through a mechanism involving the transcription factor SP-1; reduced TIMP-2 levels enhance endothelial cell migration/proliferation, tube formation in vitro, and blood vessel formation in vivo.","method":"Hypoxia chamber experiments with human primary monocytes, U937/THP-1 monocyte cell lines, and endothelial cells; TIMP-2 secretion measurement; SP-1 transcription factor analysis; Matrigel plug assay in vivo; endothelial tube formation assay","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcription factor (SP-1) mechanistic dissection, in vitro and in vivo angiogenesis readouts, single lab","pmids":["21148412"],"is_preprint":false},{"year":1994,"finding":"In late-passage human fibroblasts, TIMP-2 forms a denaturation-resistant complex with 72-kDa gelatinase (MMP-2); IL-1α increases the level of this TIMP-2:MMP-2 complex without changing individual protein levels, indicating that TIMP-2 regulates 72-kDa gelatinase activity through complex formation.","method":"Monoclonal antibody detection (Western blot, autoradiography); immunoprecipitation; early vs. late passage fibroblast culture; IL-1α stimulation","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — protein complex detection by Western/IP, single lab, limited mechanistic follow-up beyond complex detection","pmids":["8020585"],"is_preprint":false}],"current_model":"TIMP2 is a constitutively expressed extracellular protein that (1) forms a ternary complex with MT1-MMP (MMP14) and proMMP-2 at the cell surface to concentrate and activate MMP-2; (2) acts as an extracellular co-chaperone of HSP90, loading MMP-2 onto eHSP90 in an inhibited state that can be reversed by AHA1; (3) engages integrin α3β1 on endothelial cells to suppress FGF-2-driven MAPK signaling and angiogenesis; (4) binds MT1-MMP to activate Ras-ERK1/2 and AKT survival signaling in an MMP-independent, context-dependent manner; (5) protects blood-brain barrier integrity by binding α3β1 integrin to block Src-mediated VE-cadherin phosphorylation and internalization; (6) promotes renal tubular NLRP3 degradation via cAMP/MARCH7-mediated ubiquitination; (7) undergoes METTL3-mediated m6A modification that stabilizes its mRNA; (8) is transcriptionally regulated by CEBPA (activator) and MYC (repressor) in a cAMP/FSH-responsive manner, and is epigenetically silenced by EZH2-mediated H3K27me3; and (9) in the hippocampus, neuronal TIMP2 controls ECM accumulation around synapses and adult neurogenesis to support hippocampus-dependent memory through an MMP-independent mechanism."},"narrative":{"mechanistic_narrative":"TIMP2 is a constitutively secreted extracellular protein that governs pericellular proteolysis and transduces matrix-derived signals through both MMP-dependent and MMP-independent mechanisms [PMID:9422744, PMID:37914840, PMID:37321845]. Its canonical role is to organize matrix metalloproteinase activity: through N-terminal contacts it binds MT1-MMP (MMP14) while leaving the MT1-MMP C-terminal domain free to recruit proMMP-2, forming a cell-surface ternary complex that concentrates and potentiates proMMP-2 activation [PMID:9422744], and its MMP-binding interface is a sequence compromise tuned for multispecific engagement across the MMP/ADAM family rather than optimal for any single protease [PMID:24710006]. TIMP2 forms denaturation-resistant complexes with MMP-2 whose abundance is cytokine-responsive [PMID:8020585], and it acts as a stress-inducible extracellular co-chaperone of HSP90, binding eHSP90, inhibiting its ATPase activity, and loading MMP-2 into a transient inhibited state that the activating co-chaperone AHA1 reverses, constituting a molecular switch over extracellular proteolysis [PMID:31412254]. Genetic studies establish that TIMP2 is required for pathological proMMP-2 activation in renal fibrosis [PMID:23760282] and that it has roles distinct and non-redundant from TIMP3 in cardiac remodeling [PMID:24692173]. Independent of protease inhibition, TIMP2 signals through integrin α3β1: on endothelial cells it suppresses FGF-2-driven p42/44 MAPK signaling via Shp-1 to inhibit proliferation and angiogenesis [PMID:18721821], and at the blood-brain barrier it blocks Src-mediated VE-cadherin phosphorylation and internalization to preserve barrier integrity, an activity retained by an MMP-inhibition-dead mutant [PMID:38015626]. Binding to MT1-MMP also activates Ras-ERK1/2 and AKT survival signaling independent of MT1-MMP proteolysis [PMID:26331622]. In the hippocampus, neuronal TIMP2 controls perisynaptic ECM accumulation, adult neurogenesis, and memory through an MMP-independent mechanism [PMID:37914840, PMID:37321845]. In renal tubular cells TIMP2 modulates inflammatory and cell-death pathways, including NF-κB signaling [PMID:30562560], BiP-dependent ER stress [PMID:35218571], and cAMP/MARCH7-mediated NLRP3 ubiquitination and degradation [PMID:38497110]. TIMP2 expression is controlled transcriptionally by CEBPA and MYC in a cAMP/FSH-responsive manner [PMID:21832167], by SP-1 under hypoxia [PMID:21148412], and is epigenetically silenced by EZH2-mediated H3K27me3 in cancer [PMID:28620234, PMID:29636998], while its mRNA is stabilized by METTL3-mediated m6A modification [PMID:34995800].","teleology":[{"year":1994,"claim":"Established that TIMP2 regulates gelatinase activity by forming a stable physical complex with MMP-2 rather than acting solely as a free inhibitor, and that this complex is cytokine-responsive.","evidence":"Immunoprecipitation and Western detection of denaturation-resistant TIMP-2:MMP-2 complex in IL-1α-stimulated human fibroblasts","pmids":["8020585"],"confidence":"Medium","gaps":["Did not map binding interface or define activation versus inhibition outcome","Limited mechanistic follow-up beyond complex detection"]},{"year":1998,"claim":"Resolved how TIMP2 functions as an activator rather than only an inhibitor, showing it bridges MT1-MMP and proMMP-2 into a cell-surface complex that concentrates and potentiates proMMP-2 activation.","evidence":"Domain mutagenesis of MT1-MMP and progelatinase A, soluble constructs, and TIMP2-depleted HT1080 membranes","pmids":["9422744"],"confidence":"High","gaps":["Did not establish stoichiometry in vivo","Physiological triggers of complex assembly unaddressed"]},{"year":1998,"claim":"First indicated that TIMP2 has MMP-independent effects on tumor phenotype, separating its anti-invasive/anti-angiogenic actions from effects on apoptosis and necrosis.","evidence":"Stable TIMP2 overexpression in B16F10 melanoma with in vitro invasion, in vivo angiogenesis, and cell-death readouts","pmids":["9462715"],"confidence":"Medium","gaps":["No receptor or signaling mechanism identified for MMP-independent effects","Single cell line"]},{"year":2008,"claim":"Identified integrin α3β1 as a TIMP2 receptor mediating MMP-independent suppression of endothelial proliferation through Shp-1-dependent inhibition of MAPK.","evidence":"Blocking antibodies, integrin α3 siRNA, and dominant-negative Shp-1 in human microvascular endothelial cells","pmids":["18721821"],"confidence":"High","gaps":["Did not define how integrin engagement activates Shp-1","Restricted to FGF-2-driven signaling"]},{"year":2010,"claim":"Linked the angiogenic microenvironment to TIMP2 levels, showing hypoxia transcriptionally suppresses TIMP-2 via SP-1 to enable endothelial migration and vessel formation.","evidence":"Hypoxia chamber experiments in monocytes and endothelial cells with SP-1 analysis and Matrigel plug assays","pmids":["21148412"],"confidence":"Medium","gaps":["Direct SP-1 promoter occupancy not fully mapped","Mechanism connecting hypoxia to SP-1 activity unresolved"]},{"year":2011,"claim":"Defined a hormone-responsive transcriptional circuit for TIMP2, with CEBPA activating and MYC repressing the promoter under cAMP/FSH control.","evidence":"Promoter deletion mapping, reporter assays, and FSH/forskolin rescue in rat Sertoli cells","pmids":["21832167"],"confidence":"Medium","gaps":["Tissue specificity of this circuit beyond Sertoli cells unknown","Direct CEBPA/MYC binding sites not individually validated"]},{"year":2013,"claim":"Demonstrated genetically that TIMP2 is required for pathological proMMP-2 activation in vivo and drives renal tubulointerstitial fibrosis, in contrast to protective TIMP3.","evidence":"TIMP2−/− and TIMP3−/− mice in ureteral obstruction with MMP2 activation and fibrosis readouts","pmids":["23760282"],"confidence":"High","gaps":["Did not dissect whether fibrosis is purely MMP2-dependent","Cell type driving activation in vivo not defined"]},{"year":2014,"claim":"Established that TIMP2 and TIMP3 have non-redundant tissue functions, with TIMP2 governing hypertrophy and collagen cross-linking enzymes independent of shared MMP-inhibitory activity.","evidence":"TIMP2−/− and TIMP3−/− mice under angiotensin II infusion with echocardiography, histology, and LOX/PLOD1 measurement","pmids":["24692173"],"confidence":"High","gaps":["Molecular basis for LOX/PLOD1 regulation by TIMP2 not defined","Receptor mediating cardiac effect unidentified"]},{"year":2014,"claim":"Showed at the sequence level that the TIMP2 MMP-binding interface is a multispecific compromise, explaining its broad inhibition across the MMP/ADAM family.","evidence":"Computational saturation mutagenesis with SPR validation of point mutants against MMP14","pmids":["24710006"],"confidence":"Medium","gaps":["Affinity changes not tested across the full panel of 26+ family members","In vivo consequence of engineered high-affinity mutants untested"]},{"year":2014,"claim":"Provided functional evidence that a TIMP2 promoter polymorphism alters expression and implicated NF-κB as a transcriptional regulator.","evidence":"Promoter-reporter luciferase assays and EMSA for NF-κB on rs8179096 alleles","pmids":["24799419"],"confidence":"Medium","gaps":["Did not establish NF-κB regulation in physiological context","Allelic effect on protein levels in tissue not shown"]},{"year":2015,"claim":"Defined a proteolysis-independent signaling output of the TIMP2/MT1-MMP complex, showing it activates Ras-ERK1/2 and AKT to confer apoptosis resistance.","evidence":"Proteolytically inactive MT1-MMP mutants, FGFR-1 inhibition, dominant-negative Ras, and apoptosis assays","pmids":["26331622"],"confidence":"Medium","gaps":["Differential receptor requirements (FGFR-1 for ERK but not AKT) not mechanistically resolved","Context dependence of pro- versus anti-apoptotic effect unexplained"]},{"year":2017,"claim":"Identified megalin/LRP-2 as the endocytic receptor clearing the proMMP-2:TIMP-2 complex, defining a route for extracellular removal of the complex.","evidence":"RAP inhibition, anti-megalin antibodies, SPR direct binding, and conditional renal megalin KO mice with urinary accumulation","pmids":["28659595"],"confidence":"High","gaps":["Did not establish post-endocytic fate of TIMP2","Relevance outside kidney/yolk sac uptake not addressed"]},{"year":2017,"claim":"Established epigenetic silencing of TIMP2 by EZH2-mediated H3K27me3 as a driver of MMP-2/9 activity and cancer invasion.","evidence":"ChIP for EZH2/H3K27me3 at the TIMP2 promoter with EZH2 perturbation and TIMP2 rescue in ovarian cancer cells and xenografts","pmids":["28620234"],"confidence":"Medium","gaps":["Relative contributions of H3K27me3 versus DNA methylation not separated","Upstream signals driving EZH2 recruitment unknown"]},{"year":2018,"claim":"Replicated EZH2-mediated TIMP2 silencing in a second cancer type, generalizing the epigenetic axis linking TIMP2 loss to MMP-driven invasiveness.","evidence":"EZH2 perturbation with MMP-2/-9 activity, invasion, and promoter methylation analysis in TNBC cells","pmids":["29636998"],"confidence":"Medium","gaps":["Mechanistic depth lower than the ovarian study","In vivo validation limited"]},{"year":2018,"claim":"Implicated TIMP2 as a mediator of sepsis-induced acute kidney injury through NF-κB-dependent cytokine release and apoptosis in tubular cells.","evidence":"TIMP2 siRNA in HK-2 cells with LPS, p-P65 Western blot, and kidney-specific TIMP2 knockdown in CLP sepsis mice","pmids":["30562560"],"confidence":"Medium","gaps":["Direct molecular link between TIMP2 and NF-κB activation not defined","Whether effect is intracellular or receptor-mediated unresolved"]},{"year":2019,"claim":"Recast TIMP2 as an extracellular co-chaperone of HSP90 that, with AHA1, forms a reversible switch loading and inactivating MMP-2 on eHSP90.","evidence":"Co-IP, ATP binding/ATPase assays, TIMP2 and AHA1 gene knockout, blocking antibodies, and zymography in HT1080 cells","pmids":["31412254"],"confidence":"High","gaps":["Stress signals that induce TIMP2 co-chaperone function not defined","In vivo relevance of the eHSP90 switch untested"]},{"year":2022,"claim":"Identified TIMP2 interaction with the ER chaperone BiP and its facilitation of BiP secretion as a driver of ER stress in tubular injury.","evidence":"Co-IP of TIMP2 with BiP, overexpression/knockdown in HK-2 cells, and tubule-specific TIMP2 conditional KO in CLP sepsis mice","pmids":["35218571"],"confidence":"Medium","gaps":["Reciprocal interaction validation limited to single Co-IP","Subcellular site of TIMP2/BiP interaction unclear"]},{"year":2022,"claim":"Showed TIMP2 mRNA is stabilized by METTL3-mediated m6A modification via the reader IGF2BP2, linking m6A regulation to Notch-driven podocyte injury in diabetic nephropathy.","evidence":"METTL3 perturbation, podocyte-conditional METTL3 KO mice, MeRIP/m6A sequencing, and IGF2BP2 reader identification","pmids":["34995800"],"confidence":"Medium","gaps":["Direct m6A site mapping on TIMP2 not single-base resolved","Causal chain from TIMP2 to Notch incompletely defined"]},{"year":2022,"claim":"Demonstrated that fibroblast-derived TIMP2 repairs blood-brain barrier damage by upregulating tight junction proteins via a paracellular mechanism.","evidence":"Col1α1+ fibroblast ablation mice in intracerebral hemorrhage with exogenous TIMP2 rescue and BBB permeability/tight junction readouts","pmids":["36417884"],"confidence":"Medium","gaps":["Receptor mediating TIMP2 effect on tight junctions not identified here","MMP dependence not directly tested"]},{"year":2023,"claim":"Defined an MMP-independent BBB-protective mechanism in which TIMP2 engages integrin α3β1 to block Src-mediated VE-cadherin phosphorylation and internalization, stabilizing endothelial junctions.","evidence":"MMP-inhibition-dead AlaTIMP2 mutant in a TBI mouse model and human brain microvascular endothelial cells with Src, VE-cadherin, and Rac1 readouts","pmids":["38015626"],"confidence":"High","gaps":["How integrin α3β1 engagement suppresses Src not detailed","Relationship to the fibroblast-derived TIMP2 tight-junction mechanism unintegrated"]},{"year":2023,"claim":"Established a neuronal, MMP-independent role for TIMP2 in controlling perisynaptic ECM, adult neurogenesis, and hippocampus-dependent memory.","evidence":"Neuronal conditional TIMP2 KO, Ala-TIMP2 MMP-dead treatment, behavioral memory tests, and neurogenesis/ECM imaging, replicated by an independent group","pmids":["37914840","37321845"],"confidence":"High","gaps":["Molecular receptor mediating neuronal TIMP2 effects unidentified","How TIMP2 controls ECM density independent of MMP inhibition unresolved"]},{"year":2024,"claim":"Defined a cAMP/MARCH7 axis by which extracellular TIMP2 drives autophagy-dependent NLRP3 degradation to suppress pyroptosis in sepsis-AKI.","evidence":"Tubule-specific Timp2 KO with recombinant TIMP2 rescue, cAMP measurement, NLRP3 ubiquitination, MARCH7 identification, and pyroptosis markers","pmids":["38497110"],"confidence":"Medium","gaps":["Receptor coupling extracellular TIMP2 to cAMP elevation unidentified","Direct demonstration of MARCH7-NLRP3 ubiquitination link in vivo limited"]},{"year":null,"claim":"The cell-surface receptor(s) that couple TIMP2 to its diverse MMP-independent outputs (cAMP elevation, NLRP3 degradation, neuronal ECM control, cardiac LOX/PLOD1 regulation) remain undefined, leaving the unifying logic across tissues unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single receptor links the cAMP, neuronal, and cardiac MMP-independent phenotypes","Whether integrin α3β1 mediates outputs beyond endothelium is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,4,7,21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,3,11]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,20,21]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,11]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,6,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,17,18]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3,10]}],"complexes":["MT1-MMP:TIMP2:proMMP-2 ternary complex","eHSP90:TIMP2:MMP-2 complex","TIMP-2:MMP-2 complex"],"partners":["MMP14","MMP2","HSP90","AHA1","ITGA3","BIP","MARCH7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P16035","full_name":"Metalloproteinase inhibitor 2","aliases":["CSC-21K","Tissue inhibitor of metalloproteinases 2","TIMP-2"],"length_aa":220,"mass_kda":24.4,"function":"Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-13, MMP-14, MMP-15, MMP-16 and MMP-19","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P16035/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TIMP2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TIMP2","total_profiled":1310},"omim":[{"mim_id":"607151","title":"MOYAMOYA DISEASE 2; MYMY2","url":"https://www.omim.org/entry/607151"},{"mim_id":"601915","title":"TISSUE INHIBITOR OF METALLOPROTEINASE 4; TIMP4","url":"https://www.omim.org/entry/601915"},{"mim_id":"600852","title":"RETINITIS PIGMENTOSA 17; RP17","url":"https://www.omim.org/entry/600852"},{"mim_id":"600754","title":"MATRIX METALLOPROTEINASE 14; MMP14","url":"https://www.omim.org/entry/600754"},{"mim_id":"188826","title":"TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3","url":"https://www.omim.org/entry/188826"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TIMP2"},"hgnc":{"alias_symbol":["CSC-21K"],"prev_symbol":[]},"alphafold":{"accession":"P16035","domains":[{"cath_id":"2.40.50.120","chopping":"41-134","consensus_level":"high","plddt":96.089,"start":41,"end":134},{"cath_id":"3.90.370.10","chopping":"137-215","consensus_level":"high","plddt":92.3586,"start":137,"end":215}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16035","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16035-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16035-F1-predicted_aligned_error_v6.png","plddt_mean":91.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TIMP2","jax_strain_url":"https://www.jax.org/strain/search?query=TIMP2"},"sequence":{"accession":"P16035","fasta_url":"https://rest.uniprot.org/uniprotkb/P16035.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16035/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16035"}},"corpus_meta":[{"pmid":"9422744","id":"PMC_9422744","title":"The TIMP2 membrane type 1 metalloproteinase \"receptor\" regulates the concentration and efficient activation of progelatinase A. A kinetic study.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9422744","citation_count":528,"is_preprint":false},{"pmid":"9462715","id":"PMC_9462715","title":"TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis.","date":"1998","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9462715","citation_count":234,"is_preprint":false},{"pmid":"34995800","id":"PMC_34995800","title":"METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy.","date":"2022","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34995800","citation_count":174,"is_preprint":false},{"pmid":"22262409","id":"PMC_22262409","title":"In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.","date":"2012","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22262409","citation_count":174,"is_preprint":false},{"pmid":"9174126","id":"PMC_9174126","title":"In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.","date":"1997","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/9174126","citation_count":152,"is_preprint":false},{"pmid":"17505812","id":"PMC_17505812","title":"MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2.","date":"2007","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/17505812","citation_count":127,"is_preprint":false},{"pmid":"27191265","id":"PMC_27191265","title":"Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27191265","citation_count":114,"is_preprint":false},{"pmid":"11400152","id":"PMC_11400152","title":"Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.","date":"2001","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11400152","citation_count":104,"is_preprint":false},{"pmid":"12714042","id":"PMC_12714042","title":"Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis.","date":"2003","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12714042","citation_count":103,"is_preprint":false},{"pmid":"24692173","id":"PMC_24692173","title":"Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.","date":"2014","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/24692173","citation_count":100,"is_preprint":false},{"pmid":"1639268","id":"PMC_1639268","title":"Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts.","date":"1992","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/1639268","citation_count":100,"is_preprint":false},{"pmid":"29763380","id":"PMC_29763380","title":"Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29763380","citation_count":98,"is_preprint":false},{"pmid":"29859935","id":"PMC_29859935","title":"Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29859935","citation_count":95,"is_preprint":false},{"pmid":"29980651","id":"PMC_29980651","title":"Mechanisms Underlying Increased TIMP2 and IGFBP7 Urinary Excretion in Experimental AKI.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/29980651","citation_count":94,"is_preprint":false},{"pmid":"15935631","id":"PMC_15935631","title":"Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.","date":"2005","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15935631","citation_count":88,"is_preprint":false},{"pmid":"22685266","id":"PMC_22685266","title":"miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.","date":"2012","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22685266","citation_count":83,"is_preprint":false},{"pmid":"21261731","id":"PMC_21261731","title":"Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.","date":"2011","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/21261731","citation_count":79,"is_preprint":false},{"pmid":"29636998","id":"PMC_29636998","title":"EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29636998","citation_count":79,"is_preprint":false},{"pmid":"8322893","id":"PMC_8322893","title":"Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA.","date":"1993","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8322893","citation_count":78,"is_preprint":false},{"pmid":"25731730","id":"PMC_25731730","title":"MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25731730","citation_count":73,"is_preprint":false},{"pmid":"28620234","id":"PMC_28620234","title":"EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28620234","citation_count":72,"is_preprint":false},{"pmid":"10586929","id":"PMC_10586929","title":"Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes.","date":"1999","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/10586929","citation_count":68,"is_preprint":false},{"pmid":"31412254","id":"PMC_31412254","title":"Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31412254","citation_count":67,"is_preprint":false},{"pmid":"11773977","id":"PMC_11773977","title":"Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.","date":"2001","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/11773977","citation_count":64,"is_preprint":false},{"pmid":"35443741","id":"PMC_35443741","title":"Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35443741","citation_count":63,"is_preprint":false},{"pmid":"9722003","id":"PMC_9722003","title":"Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.","date":"1998","source":"Journal of pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/9722003","citation_count":63,"is_preprint":false},{"pmid":"7591285","id":"PMC_7591285","title":"Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7591285","citation_count":62,"is_preprint":false},{"pmid":"30562560","id":"PMC_30562560","title":"Downregulation of TIMP2 attenuates sepsis-induced AKI through the NF-κb pathway.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30562560","citation_count":60,"is_preprint":false},{"pmid":"24440352","id":"PMC_24440352","title":"MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24440352","citation_count":60,"is_preprint":false},{"pmid":"31621840","id":"PMC_31621840","title":"TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31621840","citation_count":59,"is_preprint":false},{"pmid":"20887771","id":"PMC_20887771","title":"Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallopeptidase inhibitor TIMP2 participate in maternal preparation of pregnancy.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20887771","citation_count":59,"is_preprint":false},{"pmid":"30179848","id":"PMC_30179848","title":"Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.","date":"2019","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30179848","citation_count":59,"is_preprint":false},{"pmid":"27386931","id":"PMC_27386931","title":"Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.","date":"2016","source":"Otolaryngologia polska = The Polish otolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/27386931","citation_count":58,"is_preprint":false},{"pmid":"23760282","id":"PMC_23760282","title":"TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury.","date":"2013","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/23760282","citation_count":56,"is_preprint":false},{"pmid":"31545237","id":"PMC_31545237","title":"LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31545237","citation_count":55,"is_preprint":false},{"pmid":"26278569","id":"PMC_26278569","title":"MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26278569","citation_count":53,"is_preprint":false},{"pmid":"8410600","id":"PMC_8410600","title":"Expression of TIMP-1, TIMP-2 and collagenase mRNA in periodontitis-affected human gingival tissue.","date":"1993","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/8410600","citation_count":51,"is_preprint":false},{"pmid":"31970775","id":"PMC_31970775","title":"Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31970775","citation_count":49,"is_preprint":false},{"pmid":"26331622","id":"PMC_26331622","title":"TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26331622","citation_count":49,"is_preprint":false},{"pmid":"34798882","id":"PMC_34798882","title":"MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.","date":"2021","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/34798882","citation_count":47,"is_preprint":false},{"pmid":"23491141","id":"PMC_23491141","title":"Polymorphic variation within the ADAMTS2, ADAMTS14, ADAMTS5, ADAM12 and TIMP2 genes and the risk of Achilles tendon pathology: a genetic association study.","date":"2013","source":"Journal of science and medicine in sport","url":"https://pubmed.ncbi.nlm.nih.gov/23491141","citation_count":47,"is_preprint":false},{"pmid":"29220395","id":"PMC_29220395","title":"MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29220395","citation_count":45,"is_preprint":false},{"pmid":"24710006","id":"PMC_24710006","title":"Affinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPs.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24710006","citation_count":44,"is_preprint":false},{"pmid":"35436325","id":"PMC_35436325","title":"Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.","date":"2022","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/35436325","citation_count":43,"is_preprint":false},{"pmid":"18721821","id":"PMC_18721821","title":"TIMP-2 disrupts FGF-2-induced downstream signaling pathways.","date":"2008","source":"Microvascular research","url":"https://pubmed.ncbi.nlm.nih.gov/18721821","citation_count":42,"is_preprint":false},{"pmid":"28392366","id":"PMC_28392366","title":"miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/28392366","citation_count":40,"is_preprint":false},{"pmid":"38015626","id":"PMC_38015626","title":"TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38015626","citation_count":39,"is_preprint":false},{"pmid":"14695775","id":"PMC_14695775","title":"Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis.","date":"2004","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/14695775","citation_count":39,"is_preprint":false},{"pmid":"33023532","id":"PMC_33023532","title":"TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33023532","citation_count":39,"is_preprint":false},{"pmid":"29393341","id":"PMC_29393341","title":"MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29393341","citation_count":39,"is_preprint":false},{"pmid":"21462296","id":"PMC_21462296","title":"Variation in FGF1, FOXE1, and TIMP2 genes is associated with nonsyndromic cleft lip with or without cleft palate.","date":"2011","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/21462296","citation_count":39,"is_preprint":false},{"pmid":"30719206","id":"PMC_30719206","title":"Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30719206","citation_count":34,"is_preprint":false},{"pmid":"8020585","id":"PMC_8020585","title":"Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts.","date":"1994","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/8020585","citation_count":33,"is_preprint":false},{"pmid":"31568657","id":"PMC_31568657","title":"lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31568657","citation_count":33,"is_preprint":false},{"pmid":"12439941","id":"PMC_12439941","title":"Expression of MMP-2,TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance.","date":"2002","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12439941","citation_count":32,"is_preprint":false},{"pmid":"35218571","id":"PMC_35218571","title":"TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35218571","citation_count":31,"is_preprint":false},{"pmid":"36417884","id":"PMC_36417884","title":"Fibroblasts repair blood-brain barrier damage and hemorrhagic brain injury via TIMP2.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36417884","citation_count":31,"is_preprint":false},{"pmid":"34638439","id":"PMC_34638439","title":"TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34638439","citation_count":30,"is_preprint":false},{"pmid":"26191221","id":"PMC_26191221","title":"miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26191221","citation_count":30,"is_preprint":false},{"pmid":"27222816","id":"PMC_27222816","title":"MMP3 and TIMP2 gene variants as predisposing factors for Achilles tendon pathologies: Attempted replication study in a British case-control cohort.","date":"2016","source":"Meta gene","url":"https://pubmed.ncbi.nlm.nih.gov/27222816","citation_count":30,"is_preprint":false},{"pmid":"26571175","id":"PMC_26571175","title":"MicroRNA-221 Regulates Hypertrophy of Ligamentum Flavum in Lumbar Spinal Stenosis by Targeting TIMP-2.","date":"2016","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/26571175","citation_count":30,"is_preprint":false},{"pmid":"22754717","id":"PMC_22754717","title":"Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa.","date":"2012","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/22754717","citation_count":29,"is_preprint":false},{"pmid":"23195431","id":"PMC_23195431","title":"CD133 affects the invasive ability of HCT116 cells by regulating TIMP-2.","date":"2012","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23195431","citation_count":29,"is_preprint":false},{"pmid":"17847032","id":"PMC_17847032","title":"Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.","date":"2008","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17847032","citation_count":29,"is_preprint":false},{"pmid":"22512703","id":"PMC_22512703","title":"Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture.","date":"2012","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/22512703","citation_count":27,"is_preprint":false},{"pmid":"35022331","id":"PMC_35022331","title":"TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35022331","citation_count":27,"is_preprint":false},{"pmid":"26464662","id":"PMC_26464662","title":"MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26464662","citation_count":27,"is_preprint":false},{"pmid":"24526442","id":"PMC_24526442","title":"Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24526442","citation_count":26,"is_preprint":false},{"pmid":"32542727","id":"PMC_32542727","title":"Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.","date":"2020","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/32542727","citation_count":25,"is_preprint":false},{"pmid":"28871006","id":"PMC_28871006","title":"Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.","date":"2017","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/28871006","citation_count":23,"is_preprint":false},{"pmid":"32626912","id":"PMC_32626912","title":"Circular RNA derived from TIMP2 functions as a competitive endogenous RNA and regulates intervertebral disc degeneration by targeting miR‑185‑5p and matrix metalloproteinase 2.","date":"2020","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32626912","citation_count":23,"is_preprint":false},{"pmid":"37914840","id":"PMC_37914840","title":"Neuronal TIMP2 regulates hippocampus-dependent plasticity and extracellular matrix complexity.","date":"2023","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37914840","citation_count":22,"is_preprint":false},{"pmid":"37664566","id":"PMC_37664566","title":"TIMP-2 and IGFBP7 in human kidney biopsies in renal disease.","date":"2023","source":"Clinical kidney journal","url":"https://pubmed.ncbi.nlm.nih.gov/37664566","citation_count":22,"is_preprint":false},{"pmid":"36291151","id":"PMC_36291151","title":"Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36291151","citation_count":22,"is_preprint":false},{"pmid":"21832167","id":"PMC_21832167","title":"Transcriptional suppression of Sertoli cell Timp2 in rodents following mono-(2-ethylhexyl) phthalate exposure is regulated by CEBPA and MYC.","date":"2011","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21832167","citation_count":22,"is_preprint":false},{"pmid":"22555040","id":"PMC_22555040","title":"Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.","date":"2012","source":"International braz j urol : official journal of the Brazilian Society of Urology","url":"https://pubmed.ncbi.nlm.nih.gov/22555040","citation_count":22,"is_preprint":false},{"pmid":"36980601","id":"PMC_36980601","title":"MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36980601","citation_count":21,"is_preprint":false},{"pmid":"22551568","id":"PMC_22551568","title":"NUR77 inhibits the expression of TIMP2 and increases the migration and invasion of HTR-8/SVneo cells induced by CYR61.","date":"2012","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/22551568","citation_count":21,"is_preprint":false},{"pmid":"30755371","id":"PMC_30755371","title":"Are MMP3, MMP8 and TIMP2 gene variants associated with anterior cruciate ligament rupture susceptibility?","date":"2019","source":"Journal of science and medicine in sport","url":"https://pubmed.ncbi.nlm.nih.gov/30755371","citation_count":20,"is_preprint":false},{"pmid":"28498424","id":"PMC_28498424","title":"MicroRNA-15b promotes proliferation and invasion of non‑small cell lung carcinoma cells by directly targeting TIMP2.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28498424","citation_count":20,"is_preprint":false},{"pmid":"20233321","id":"PMC_20233321","title":"Involvement of MT1-MMP and TIMP-2 in human periodontal disease.","date":"2010","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20233321","citation_count":20,"is_preprint":false},{"pmid":"20434371","id":"PMC_20434371","title":"Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.","date":"2010","source":"Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20434371","citation_count":20,"is_preprint":false},{"pmid":"24939826","id":"PMC_24939826","title":"Expression of MMP-2, MT1-MMP, and TIMP-2 by cultured rabbit corneal fibroblasts under mechanical stretch.","date":"2014","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24939826","citation_count":20,"is_preprint":false},{"pmid":"38497110","id":"PMC_38497110","title":"TIMP2 protects against sepsis-associated acute kidney injury by cAMP/NLRP3 axis-mediated pyroptosis.","date":"2024","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38497110","citation_count":19,"is_preprint":false},{"pmid":"24799419","id":"PMC_24799419","title":"Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate.","date":"2014","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/24799419","citation_count":19,"is_preprint":false},{"pmid":"28510611","id":"PMC_28510611","title":"MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.","date":"2017","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/28510611","citation_count":19,"is_preprint":false},{"pmid":"26314845","id":"PMC_26314845","title":"An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26314845","citation_count":18,"is_preprint":false},{"pmid":"35523402","id":"PMC_35523402","title":"USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-κB/PD-L1 axis to promote the development of cervical cancer.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/35523402","citation_count":18,"is_preprint":false},{"pmid":"35851988","id":"PMC_35851988","title":"seRNA PAM controls skeletal muscle satellite cell proliferation and aging through trans regulation of Timp2 expression synergistically with Ddx5.","date":"2022","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/35851988","citation_count":18,"is_preprint":false},{"pmid":"31452731","id":"PMC_31452731","title":"miR-616 promotes breast cancer migration and invasion by targeting TIMP2 and regulating MMP signaling.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31452731","citation_count":17,"is_preprint":false},{"pmid":"9385361","id":"PMC_9385361","title":"Retinitis pigmentosa locus on 17q (RP17): fine localization to 17q22 and exclusion of the PDEG and TIMP2 genes.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9385361","citation_count":17,"is_preprint":false},{"pmid":"18675881","id":"PMC_18675881","title":"Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.","date":"2008","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18675881","citation_count":16,"is_preprint":false},{"pmid":"21148412","id":"PMC_21148412","title":"Reduced TIMP-2 in hypoxia enhances angiogenesis.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21148412","citation_count":16,"is_preprint":false},{"pmid":"30765222","id":"PMC_30765222","title":"MicroRNA-552 promotes migration and invasion of osteosarcoma through targeting TIMP2.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30765222","citation_count":15,"is_preprint":false},{"pmid":"34778021","id":"PMC_34778021","title":"miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34778021","citation_count":15,"is_preprint":false},{"pmid":"12969531","id":"PMC_12969531","title":"[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].","date":"2003","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12969531","citation_count":15,"is_preprint":false},{"pmid":"28659595","id":"PMC_28659595","title":"Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28659595","citation_count":14,"is_preprint":false},{"pmid":"31383784","id":"PMC_31383784","title":"MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31383784","citation_count":14,"is_preprint":false},{"pmid":"34487732","id":"PMC_34487732","title":"ESR1 mediated circ_0004018 suppresses angiogenesis in hepatocellular carcinoma via recruiting FUS and stabilizing TIMP2 expression.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34487732","citation_count":14,"is_preprint":false},{"pmid":"37321845","id":"PMC_37321845","title":"Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in Aging.","date":"2023","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/37321845","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54186,"output_tokens":6654,"usd":0.131184,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15740,"output_tokens":6891,"usd":0.125488,"stage2_stop_reason":"end_turn"},"total_usd":0.256672,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"TIMP2 binds MT1-MMP (membrane type 1 MMP) primarily through N-terminal domain interactions, leaving the C-terminal domain of MT1-MMP free to interact with progelatinase A (MMP-2). This forms a cell-surface receptor complex that concentrates progelatinase A and potentiates its activation. Residues 568-631 of the progelatinase A C-terminal domain are required for binding to both heparin and TIMP2, and for cell membrane-associated MT1-MMP-dependent activation.\",\n      \"method\": \"C-terminal domain mutants of MT1-MMP and progelatinase A, soluble MT1-MMP constructs, heparin binding assays, cell membrane preparations from HT1080 cells depleted of endogenous TIMP2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple domain mutants tested in vitro and in cell-based system, reconstitution approach with endogenous TIMP2-depleted membranes, rigorous mutagenesis mapping\",\n      \"pmids\": [\"9422744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TIMP2 over-expression in B16F10 melanoma cells reduces invasion and angiogenesis but increases resistance to apoptosis while increasing necrosis, demonstrating MMP-inhibition-dependent and MMP-inhibition-independent effects on tumor cell phenotype.\",\n      \"method\": \"Stable transfection of TIMP2 cDNA into B16F10 cells; in vitro invasion assays; in vivo Matrigel angiogenesis assay; subcutaneous tumor growth in mice; apoptosis/necrosis assays\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss/gain of function with multiple phenotypic readouts in vitro and in vivo, single lab\",\n      \"pmids\": [\"9462715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TIMP-2 inhibits FGF-2-induced p42/44 MAPK activation and endothelial cell proliferation through binding to integrin α3β1 on endothelial cell surfaces, acting upstream of Shp-1-dependent inhibition of MAPK signaling; dominant-negative Shp-1 and anti-integrin α3/β1 blocking antibodies or siRNA knockdown of integrin α3 abrogated this effect.\",\n      \"method\": \"Dominant-negative Shp-1 mutant expression; blocking antibodies against integrin α3 and β1; siRNA disruption of integrin α3; protein tyrosine phosphatase inhibitor orthovanadate; MAPK activation assays in human microvascular endothelial cells\",\n      \"journal\": \"Microvascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal perturbation methods (antibody blocking, siRNA, dominant-negative mutant) converging on same mechanism, single lab\",\n      \"pmids\": [\"18721821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TIMP-2 binding to MT1-MMP induces rapid and sustained AKT activation in a manner independent of MT1-MMP proteolytic activity but requiring Ras activation; ERK1/2 activation by TIMP-2/MT1-MMP also requires FGFR-1 but AKT activation does not. Both ERK1/2 and AKT activation protect tumor cells from serum starvation-induced apoptosis, while TIMP-2 upregulates apoptosis induced by 3D type I collagen.\",\n      \"method\": \"Dose- and time-response experiments in MT1-MMP-expressing cells; use of proteolytically inactive MT1-MMP mutants; FGFR-1 inhibition; dominant-negative Ras; apoptosis assays under serum starvation and 3D collagen conditions\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteolysis-dead mutants and multiple signaling inhibitors used, single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"26331622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TIMP2 functions as a stress-inducible extracellular co-chaperone of HSP90: it binds eHSP90, increases eHSP90 ATPase binding to ATP and inhibits its ATPase activity, disrupts the eHSP90:MMP2 complex to terminally inactivate MMP2, but also loads MMP2 onto eHSP90 in a transient inhibitory state. The activating co-chaperone AHA1 displaces TIMP2 from the complex to reactivate MMP2, forming a molecular switch regulating extracellular proteolysis.\",\n      \"method\": \"Co-immunoprecipitation; ATP binding and ATPase assays; gene knockout of TIMP2 and AHA1; blocking antibodies against TIMP2 and AHA1 in HT1080 cancer cells; gelatin zymography\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — biochemical reconstitution (ATPase assay), gene KO, blocking antibodies, and zymography, multiple orthogonal methods in one study\",\n      \"pmids\": [\"31412254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Computational saturation mutagenesis of the TIMP2 MMP-binding interface identified the interface as non-optimal for any single MMP; experimental point mutations produced >10-fold improvement in affinity to MMP14 (MT1-MMP), indicating TIMP2 sequence is a compromise for multispecific binding across 26+ MMP/ADAM family members.\",\n      \"method\": \"Computational free energy calculations (saturation mutagenesis); experimental surface plasmon resonance binding measurements of TIMP2 point mutants against MMP14\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assay with mutagenesis, computational + experimental validation, single lab\",\n      \"pmids\": [\"24710006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TIMP2 deficiency (TIMP2−/−) in mice results in enhanced myocardial hypertrophy without fibrosis following angiotensin II infusion, while TIMP3 deficiency produces the inverse (excess fibrosis without hypertrophy), demonstrating that TIMP2 and TIMP3 have distinct and non-redundant roles in cardiac remodeling independent of their shared MMP-inhibitory functions. Reduced collagen cross-linking enzymes LOX and PLOD1 underlie suppressed collagen deposition in TIMP2−/− hearts.\",\n      \"method\": \"TIMP2−/− and TIMP3−/− mouse models; angiotensin II infusion; echocardiographic imaging; in vitro co-culture of cardiomyocytes with cardiac fibroblasts; collagen cross-linking enzyme measurements\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout models with multiple orthogonal phenotypic readouts (echocardiography, histology, in vitro co-culture, biochemistry), well-controlled\",\n      \"pmids\": [\"24692173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TIMP2 promotes MMP2 activation in the kidney: ureteral obstruction markedly increased MMP2 activation in TIMP3−/− kidneys but was completely blocked in TIMP2−/− kidneys, demonstrating that TIMP2 is required for pathological pro-MMP2 activation and resultant renal tubulointerstitial fibrosis, while TIMP3 protects from damage.\",\n      \"method\": \"TIMP2−/− and TIMP3−/− mice; unilateral ureteral obstruction model; gene microarray; collagen I/III expression; MMP2 activation assays; TGF-β/Smad pathway analysis; caspase-3 and TNFR-converting enzyme activities\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO models with multiple biochemical readouts, replicated across TIMP2 and TIMP3 KO for mechanistic contrast\",\n      \"pmids\": [\"23760282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TIMP2 silencing ameliorates LPS-induced cytokine release and apoptosis in kidney tubular cells via inhibition of the NF-κB pathway (p-P65); kidney-specific TIMP2 knockdown in CLP sepsis mice reduced proinflammatory cytokines and kidney dysfunction, revealing that TIMP2 mediates sepsis-induced AKI through NF-κB regulation.\",\n      \"method\": \"siRNA knockdown of TIMP2 in HK-2 cells; LPS challenge; cytokine assays; NF-κB (p-P65) western blot; kidney-specific TIMP2 knockdown via lentiviral vector injection; CLP sepsis mouse model; serum creatinine and histopathology\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combined in vitro knockdown and in vivo kidney-specific KD with mechanistic pathway readout, single lab\",\n      \"pmids\": [\"30562560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TIMP2 interacts with BiP (binding immunoglobulin protein), an ER chaperone, and facilitates its extracellular secretion, thereby triggering ER stress; TIMP2 overexpression induces ER stress while TIMP2 knockdown attenuates LPS-induced ER stress and apoptosis; tubule-specific TIMP2 knockout mice showed decreased ER stress-mediated apoptosis in CLP-induced AKI.\",\n      \"method\": \"Co-immunoprecipitation of TIMP2 with BiP; TIMP2 overexpression and siRNA knockdown in HK-2 cells; tubule-specific TIMP2 conditional KO mice (Ksp-Cre/TIMP2flox/flox); CLP sepsis model; ER stress markers; serum creatinine; apoptosis assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for physical interaction, conditional KO with phenotypic readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35218571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Extracellular TIMP2 increases intracellular cAMP, which promotes ubiquitination of NLRP3 via the E3 ligase MARCH7 and subsequent autophagy-dependent NLRP3 degradation, attenuating pyroptosis in renal tubular cells; kidney tubule-specific Timp2 KO mice showed exacerbated pyroptosis (elevated NLRP3, Caspase1, GSDMD) in sepsis-AKI, and exogenous recombinant TIMP2 rescued this.\",\n      \"method\": \"Kidney tubule-specific Timp2 KO mice; CLP sepsis model; recombinant TIMP2 rescue experiments; LPS-stimulated primary renal tubular cells; cAMP measurement; NLRP3 ubiquitination assays; MARCH7 identification; autophagy flux assays; pyroptosis marker measurement\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO + recombinant protein rescue + mechanistic pathway (cAMP/MARCH7/NLRP3) in single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38497110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TIMP2 interacts with integrin α3β1 on brain microvascular endothelial cells, inhibiting Src activation-dependent VE-cadherin phosphorylation, VE-cadherin/catenin complex destabilization, and subsequent VE-cadherin internalization; increased membrane localization of VE-cadherin enhances Rac1 activity and inhibits stress fiber formation; an MMP-inhibition-dead mutant (AlaTIMP2) retains these BBB-protective effects, confirming MMP-independent mechanism.\",\n      \"method\": \"AlaTIMP2 (MMP-inhibitory-dead mutant); TBI mouse model; human brain microvascular endothelial cells under hypoxia/inflammation; mechanistic studies of Src phosphorylation, VE-cadherin internalization/membrane localization, Rac1 activity, and stress fiber formation; integrin α3β1 binding assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — MMP-dead mutant establishes MMP-independence, integrin binding, multiple downstream signaling readouts, in vivo mouse model plus in vitro human cell validation\",\n      \"pmids\": [\"38015626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Fibroblasts repair blood-brain barrier damage in intracerebral hemorrhage via TIMP2: Col1α1+ fibroblast ablation exacerbated BBB damage, and the protective effect was mediated by TIMP2 through upregulation of tight junction proteins via a paracellular mechanism; exogenous TIMP2 rescued BBB disruption in fibroblast-ablated mice.\",\n      \"method\": \"Col1α1-targeted fibroblast ablation mice; ICH model; in vitro BBB permeability assays; tight junction protein immunostaining; exogenous TIMP2 rescue experiments; transcytosis-associated protein analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation with exogenous rescue, multiple BBB readouts, single lab\",\n      \"pmids\": [\"36417884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Neuronal TIMP2 regulates adult hippocampal neurogenesis, dendritic spine turnover, ECM accumulation around synapses, and hippocampus-dependent memory; conditional neuronal TIMP2 knockout mice show increased ECM around synapses, impaired newborn neuron migration through denser ECM, and memory deficits; an Ala-TIMP2 mutant lacking MMP inhibition retains cognitive benefits, indicating MMP-independent mechanism for cognitive effects.\",\n      \"method\": \"Conditional TIMP2 knockout (neuronal-specific); hippocampus-dependent memory tests; adult neurogenesis and dendritic spine quantification; ECM accumulation imaging; Ala-TIMP2 (MMP-inhibitory-dead) treatment; intraperitoneal injection of TIMP2 and TIMP2-hIgG4 fusion protein in aged mice; cfos expression; synapse density (CA1, DG)\",\n      \"journal\": \"Molecular psychiatry / eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO model, MMP-dead mutant confirming MMP-independence, multiple behavioral and cellular phenotypic readouts, replicated by independent group (Britton et al. eNeuro 2023)\",\n      \"pmids\": [\"37914840\", \"37321845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The proMMP-2:TIMP-2 complex is endocytosed in rat yolk sac cells by the megalin/LRP-2 endocytic receptor; receptor-associated protein (RAP, a natural LRP antagonist) blocked accumulation of proMMP-2 and TIMP-2; anti-megalin antibodies (but not anti-LRP-1 antibodies) inhibited binding; BIAcore surface plasmon resonance confirmed direct interaction; conditional renal megalin/LRP-2 invalidation in mice caused urinary accumulation of proMMP-2 and TIMP-2.\",\n      \"method\": \"RAP inhibition; blocking antibodies against megalin/LRP-2 and LRP-1; BIAcore (SPR) direct binding assay; conditional renal megalin/LRP-2 knockout mice; radiolabeled proMMP-2:TIMP-2 uptake assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — SPR reconstitution, genetic KO in vivo, blocking antibodies and RAP inhibition, multiple orthogonal methods converging on megalin/LRP-2 as receptor\",\n      \"pmids\": [\"28659595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TIMP2 transcription in Sertoli cells is activated by the transcription factor CEBPA under basal conditions and repressed by MYC; MEHP (mono-(2-ethylhexyl) phthalate) exposure decreases CEBPA transactivation and increases MYC-mediated repression of the TIMP2 promoter; FSH rescues MEHP-suppressed TIMP2 levels via cAMP-dependent translocation of CEBPA into the nucleus.\",\n      \"method\": \"Sequential 5'-deletion mutagenesis of the TIMP2 promoter; CEBPA and MYC reporter assays in rat Sertoli cells; FSH and forskolin rescue experiments; CEBPA nuclear translocation assay; actinomycin D experiments\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion mapping, transcription factor identification with rescue experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21832167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL3-mediated m6A modification of TIMP2 mRNA promotes TIMP2 expression in podocytes in an IGF2BP2-dependent manner; elevated METTL3 in diabetic nephropathy increases m6A on TIMP2 mRNA and modulates Notch signaling to exert pro-inflammatory and pro-apoptotic effects.\",\n      \"method\": \"METTL3 knockout/overexpression in podocytes; podocyte-conditional METTL3 KO mice; AAV9-shMETTL3 in STZ-diabetic and db/db mice; m6A sequencing/MeRIP; IGF2BP2 identification as m6A reader; Notch signaling pathway readouts\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with m6A sequencing and reader identification, in vivo validation, single lab\",\n      \"pmids\": [\"34995800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"EZH2 represses TIMP2 expression via H3K27me3 and DNA methylation at the TIMP2 promoter in ovarian cancer; EZH2 overexpression promotes MMP2 and MMP9 proteolytic activities and cancer invasion/migration, effects largely reversed by TIMP2 knockdown; EZH2 and H3K27me3 presence at the TIMP2 promoter was confirmed by ChIP.\",\n      \"method\": \"ChIP for EZH2 and H3K27me3 at TIMP2 promoter; EZH2 overexpression and knockdown; H3K27me3 inhibition; TIMP2 re-expression rescue assays; in vitro invasion/migration; in vivo xenograft\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP validation of promoter occupancy, genetic perturbation with rescue, in vitro and in vivo readouts, single lab\",\n      \"pmids\": [\"28620234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"EZH2-mediated H3K27me3 at the TIMP2 promoter silences TIMP2 transcription in triple-negative breast cancer cells, resulting in increased MMP-2 and MMP-9 activity and enhanced invasiveness.\",\n      \"method\": \"EZH2 knockdown/overexpression in TNBC cells; MMP-2/-9 activity measurement; invasion assays; TIMP2 promoter methylation analysis\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic perturbation with downstream enzymatic activity readout, consistent with ovarian cancer findings (replicated finding), single lab\",\n      \"pmids\": [\"29636998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The TIMP2 rs8179096 promoter polymorphism is functional: the T allele shows 2.5-fold increased promoter activity compared to the C allele; both alleles bind nuclear factor kappa B (NF-κB), suggesting NF-κB as a transcriptional regulator of TIMP2.\",\n      \"method\": \"Promoter-reporter luciferase assays; DNA-protein binding (EMSA) for NF-κB\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter activity assay plus DNA-protein binding assay for specific transcription factor, single lab\",\n      \"pmids\": [\"24799419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hypoxia reduces TIMP-2 secretion from human monocytes and endothelial cells by inhibiting TIMP-2 transcription through a mechanism involving the transcription factor SP-1; reduced TIMP-2 levels enhance endothelial cell migration/proliferation, tube formation in vitro, and blood vessel formation in vivo.\",\n      \"method\": \"Hypoxia chamber experiments with human primary monocytes, U937/THP-1 monocyte cell lines, and endothelial cells; TIMP-2 secretion measurement; SP-1 transcription factor analysis; Matrigel plug assay in vivo; endothelial tube formation assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcription factor (SP-1) mechanistic dissection, in vitro and in vivo angiogenesis readouts, single lab\",\n      \"pmids\": [\"21148412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"In late-passage human fibroblasts, TIMP-2 forms a denaturation-resistant complex with 72-kDa gelatinase (MMP-2); IL-1α increases the level of this TIMP-2:MMP-2 complex without changing individual protein levels, indicating that TIMP-2 regulates 72-kDa gelatinase activity through complex formation.\",\n      \"method\": \"Monoclonal antibody detection (Western blot, autoradiography); immunoprecipitation; early vs. late passage fibroblast culture; IL-1α stimulation\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — protein complex detection by Western/IP, single lab, limited mechanistic follow-up beyond complex detection\",\n      \"pmids\": [\"8020585\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TIMP2 is a constitutively expressed extracellular protein that (1) forms a ternary complex with MT1-MMP (MMP14) and proMMP-2 at the cell surface to concentrate and activate MMP-2; (2) acts as an extracellular co-chaperone of HSP90, loading MMP-2 onto eHSP90 in an inhibited state that can be reversed by AHA1; (3) engages integrin α3β1 on endothelial cells to suppress FGF-2-driven MAPK signaling and angiogenesis; (4) binds MT1-MMP to activate Ras-ERK1/2 and AKT survival signaling in an MMP-independent, context-dependent manner; (5) protects blood-brain barrier integrity by binding α3β1 integrin to block Src-mediated VE-cadherin phosphorylation and internalization; (6) promotes renal tubular NLRP3 degradation via cAMP/MARCH7-mediated ubiquitination; (7) undergoes METTL3-mediated m6A modification that stabilizes its mRNA; (8) is transcriptionally regulated by CEBPA (activator) and MYC (repressor) in a cAMP/FSH-responsive manner, and is epigenetically silenced by EZH2-mediated H3K27me3; and (9) in the hippocampus, neuronal TIMP2 controls ECM accumulation around synapses and adult neurogenesis to support hippocampus-dependent memory through an MMP-independent mechanism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TIMP2 is a constitutively secreted extracellular protein that governs pericellular proteolysis and transduces matrix-derived signals through both MMP-dependent and MMP-independent mechanisms [#0, #13]. Its canonical role is to organize matrix metalloproteinase activity: through N-terminal contacts it binds MT1-MMP (MMP14) while leaving the MT1-MMP C-terminal domain free to recruit proMMP-2, forming a cell-surface ternary complex that concentrates and potentiates proMMP-2 activation [#0], and its MMP-binding interface is a sequence compromise tuned for multispecific engagement across the MMP/ADAM family rather than optimal for any single protease [#5]. TIMP2 forms denaturation-resistant complexes with MMP-2 whose abundance is cytokine-responsive [#21], and it acts as a stress-inducible extracellular co-chaperone of HSP90, binding eHSP90, inhibiting its ATPase activity, and loading MMP-2 into a transient inhibited state that the activating co-chaperone AHA1 reverses, constituting a molecular switch over extracellular proteolysis [#4]. Genetic studies establish that TIMP2 is required for pathological proMMP-2 activation in renal fibrosis [#7] and that it has roles distinct and non-redundant from TIMP3 in cardiac remodeling [#6]. Independent of protease inhibition, TIMP2 signals through integrin α3β1: on endothelial cells it suppresses FGF-2-driven p42/44 MAPK signaling via Shp-1 to inhibit proliferation and angiogenesis [#2], and at the blood-brain barrier it blocks Src-mediated VE-cadherin phosphorylation and internalization to preserve barrier integrity, an activity retained by an MMP-inhibition-dead mutant [#11]. Binding to MT1-MMP also activates Ras-ERK1/2 and AKT survival signaling independent of MT1-MMP proteolysis [#3]. In the hippocampus, neuronal TIMP2 controls perisynaptic ECM accumulation, adult neurogenesis, and memory through an MMP-independent mechanism [#13]. In renal tubular cells TIMP2 modulates inflammatory and cell-death pathways, including NF-κB signaling [#8], BiP-dependent ER stress [#9], and cAMP/MARCH7-mediated NLRP3 ubiquitination and degradation [#10]. TIMP2 expression is controlled transcriptionally by CEBPA and MYC in a cAMP/FSH-responsive manner [#15], by SP-1 under hypoxia [#20], and is epigenetically silenced by EZH2-mediated H3K27me3 in cancer [#17, #18], while its mRNA is stabilized by METTL3-mediated m6A modification [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that TIMP2 regulates gelatinase activity by forming a stable physical complex with MMP-2 rather than acting solely as a free inhibitor, and that this complex is cytokine-responsive.\",\n      \"evidence\": \"Immunoprecipitation and Western detection of denaturation-resistant TIMP-2:MMP-2 complex in IL-1α-stimulated human fibroblasts\",\n      \"pmids\": [\"8020585\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not map binding interface or define activation versus inhibition outcome\", \"Limited mechanistic follow-up beyond complex detection\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved how TIMP2 functions as an activator rather than only an inhibitor, showing it bridges MT1-MMP and proMMP-2 into a cell-surface complex that concentrates and potentiates proMMP-2 activation.\",\n      \"evidence\": \"Domain mutagenesis of MT1-MMP and progelatinase A, soluble constructs, and TIMP2-depleted HT1080 membranes\",\n      \"pmids\": [\"9422744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish stoichiometry in vivo\", \"Physiological triggers of complex assembly unaddressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"First indicated that TIMP2 has MMP-independent effects on tumor phenotype, separating its anti-invasive/anti-angiogenic actions from effects on apoptosis and necrosis.\",\n      \"evidence\": \"Stable TIMP2 overexpression in B16F10 melanoma with in vitro invasion, in vivo angiogenesis, and cell-death readouts\",\n      \"pmids\": [\"9462715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No receptor or signaling mechanism identified for MMP-independent effects\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified integrin α3β1 as a TIMP2 receptor mediating MMP-independent suppression of endothelial proliferation through Shp-1-dependent inhibition of MAPK.\",\n      \"evidence\": \"Blocking antibodies, integrin α3 siRNA, and dominant-negative Shp-1 in human microvascular endothelial cells\",\n      \"pmids\": [\"18721821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how integrin engagement activates Shp-1\", \"Restricted to FGF-2-driven signaling\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linked the angiogenic microenvironment to TIMP2 levels, showing hypoxia transcriptionally suppresses TIMP-2 via SP-1 to enable endothelial migration and vessel formation.\",\n      \"evidence\": \"Hypoxia chamber experiments in monocytes and endothelial cells with SP-1 analysis and Matrigel plug assays\",\n      \"pmids\": [\"21148412\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct SP-1 promoter occupancy not fully mapped\", \"Mechanism connecting hypoxia to SP-1 activity unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined a hormone-responsive transcriptional circuit for TIMP2, with CEBPA activating and MYC repressing the promoter under cAMP/FSH control.\",\n      \"evidence\": \"Promoter deletion mapping, reporter assays, and FSH/forskolin rescue in rat Sertoli cells\",\n      \"pmids\": [\"21832167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue specificity of this circuit beyond Sertoli cells unknown\", \"Direct CEBPA/MYC binding sites not individually validated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated genetically that TIMP2 is required for pathological proMMP-2 activation in vivo and drives renal tubulointerstitial fibrosis, in contrast to protective TIMP3.\",\n      \"evidence\": \"TIMP2−/− and TIMP3−/− mice in ureteral obstruction with MMP2 activation and fibrosis readouts\",\n      \"pmids\": [\"23760282\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not dissect whether fibrosis is purely MMP2-dependent\", \"Cell type driving activation in vivo not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that TIMP2 and TIMP3 have non-redundant tissue functions, with TIMP2 governing hypertrophy and collagen cross-linking enzymes independent of shared MMP-inhibitory activity.\",\n      \"evidence\": \"TIMP2−/− and TIMP3−/− mice under angiotensin II infusion with echocardiography, histology, and LOX/PLOD1 measurement\",\n      \"pmids\": [\"24692173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for LOX/PLOD1 regulation by TIMP2 not defined\", \"Receptor mediating cardiac effect unidentified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed at the sequence level that the TIMP2 MMP-binding interface is a multispecific compromise, explaining its broad inhibition across the MMP/ADAM family.\",\n      \"evidence\": \"Computational saturation mutagenesis with SPR validation of point mutants against MMP14\",\n      \"pmids\": [\"24710006\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Affinity changes not tested across the full panel of 26+ family members\", \"In vivo consequence of engineered high-affinity mutants untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Provided functional evidence that a TIMP2 promoter polymorphism alters expression and implicated NF-κB as a transcriptional regulator.\",\n      \"evidence\": \"Promoter-reporter luciferase assays and EMSA for NF-κB on rs8179096 alleles\",\n      \"pmids\": [\"24799419\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish NF-κB regulation in physiological context\", \"Allelic effect on protein levels in tissue not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a proteolysis-independent signaling output of the TIMP2/MT1-MMP complex, showing it activates Ras-ERK1/2 and AKT to confer apoptosis resistance.\",\n      \"evidence\": \"Proteolytically inactive MT1-MMP mutants, FGFR-1 inhibition, dominant-negative Ras, and apoptosis assays\",\n      \"pmids\": [\"26331622\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Differential receptor requirements (FGFR-1 for ERK but not AKT) not mechanistically resolved\", \"Context dependence of pro- versus anti-apoptotic effect unexplained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified megalin/LRP-2 as the endocytic receptor clearing the proMMP-2:TIMP-2 complex, defining a route for extracellular removal of the complex.\",\n      \"evidence\": \"RAP inhibition, anti-megalin antibodies, SPR direct binding, and conditional renal megalin KO mice with urinary accumulation\",\n      \"pmids\": [\"28659595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish post-endocytic fate of TIMP2\", \"Relevance outside kidney/yolk sac uptake not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established epigenetic silencing of TIMP2 by EZH2-mediated H3K27me3 as a driver of MMP-2/9 activity and cancer invasion.\",\n      \"evidence\": \"ChIP for EZH2/H3K27me3 at the TIMP2 promoter with EZH2 perturbation and TIMP2 rescue in ovarian cancer cells and xenografts\",\n      \"pmids\": [\"28620234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of H3K27me3 versus DNA methylation not separated\", \"Upstream signals driving EZH2 recruitment unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Replicated EZH2-mediated TIMP2 silencing in a second cancer type, generalizing the epigenetic axis linking TIMP2 loss to MMP-driven invasiveness.\",\n      \"evidence\": \"EZH2 perturbation with MMP-2/-9 activity, invasion, and promoter methylation analysis in TNBC cells\",\n      \"pmids\": [\"29636998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic depth lower than the ovarian study\", \"In vivo validation limited\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Implicated TIMP2 as a mediator of sepsis-induced acute kidney injury through NF-κB-dependent cytokine release and apoptosis in tubular cells.\",\n      \"evidence\": \"TIMP2 siRNA in HK-2 cells with LPS, p-P65 Western blot, and kidney-specific TIMP2 knockdown in CLP sepsis mice\",\n      \"pmids\": [\"30562560\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link between TIMP2 and NF-κB activation not defined\", \"Whether effect is intracellular or receptor-mediated unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Recast TIMP2 as an extracellular co-chaperone of HSP90 that, with AHA1, forms a reversible switch loading and inactivating MMP-2 on eHSP90.\",\n      \"evidence\": \"Co-IP, ATP binding/ATPase assays, TIMP2 and AHA1 gene knockout, blocking antibodies, and zymography in HT1080 cells\",\n      \"pmids\": [\"31412254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stress signals that induce TIMP2 co-chaperone function not defined\", \"In vivo relevance of the eHSP90 switch untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified TIMP2 interaction with the ER chaperone BiP and its facilitation of BiP secretion as a driver of ER stress in tubular injury.\",\n      \"evidence\": \"Co-IP of TIMP2 with BiP, overexpression/knockdown in HK-2 cells, and tubule-specific TIMP2 conditional KO in CLP sepsis mice\",\n      \"pmids\": [\"35218571\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reciprocal interaction validation limited to single Co-IP\", \"Subcellular site of TIMP2/BiP interaction unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed TIMP2 mRNA is stabilized by METTL3-mediated m6A modification via the reader IGF2BP2, linking m6A regulation to Notch-driven podocyte injury in diabetic nephropathy.\",\n      \"evidence\": \"METTL3 perturbation, podocyte-conditional METTL3 KO mice, MeRIP/m6A sequencing, and IGF2BP2 reader identification\",\n      \"pmids\": [\"34995800\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct m6A site mapping on TIMP2 not single-base resolved\", \"Causal chain from TIMP2 to Notch incompletely defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that fibroblast-derived TIMP2 repairs blood-brain barrier damage by upregulating tight junction proteins via a paracellular mechanism.\",\n      \"evidence\": \"Col1α1+ fibroblast ablation mice in intracerebral hemorrhage with exogenous TIMP2 rescue and BBB permeability/tight junction readouts\",\n      \"pmids\": [\"36417884\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating TIMP2 effect on tight junctions not identified here\", \"MMP dependence not directly tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined an MMP-independent BBB-protective mechanism in which TIMP2 engages integrin α3β1 to block Src-mediated VE-cadherin phosphorylation and internalization, stabilizing endothelial junctions.\",\n      \"evidence\": \"MMP-inhibition-dead AlaTIMP2 mutant in a TBI mouse model and human brain microvascular endothelial cells with Src, VE-cadherin, and Rac1 readouts\",\n      \"pmids\": [\"38015626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How integrin α3β1 engagement suppresses Src not detailed\", \"Relationship to the fibroblast-derived TIMP2 tight-junction mechanism unintegrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established a neuronal, MMP-independent role for TIMP2 in controlling perisynaptic ECM, adult neurogenesis, and hippocampus-dependent memory.\",\n      \"evidence\": \"Neuronal conditional TIMP2 KO, Ala-TIMP2 MMP-dead treatment, behavioral memory tests, and neurogenesis/ECM imaging, replicated by an independent group\",\n      \"pmids\": [\"37914840\", \"37321845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular receptor mediating neuronal TIMP2 effects unidentified\", \"How TIMP2 controls ECM density independent of MMP inhibition unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a cAMP/MARCH7 axis by which extracellular TIMP2 drives autophagy-dependent NLRP3 degradation to suppress pyroptosis in sepsis-AKI.\",\n      \"evidence\": \"Tubule-specific Timp2 KO with recombinant TIMP2 rescue, cAMP measurement, NLRP3 ubiquitination, MARCH7 identification, and pyroptosis markers\",\n      \"pmids\": [\"38497110\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor coupling extracellular TIMP2 to cAMP elevation unidentified\", \"Direct demonstration of MARCH7-NLRP3 ubiquitination link in vivo limited\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The cell-surface receptor(s) that couple TIMP2 to its diverse MMP-independent outputs (cAMP elevation, NLRP3 degradation, neuronal ECM control, cardiac LOX/PLOD1 regulation) remain undefined, leaving the unifying logic across tissues unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No single receptor links the cAMP, neuronal, and cardiac MMP-independent phenotypes\", \"Whether integrin α3β1 mediates outputs beyond endothelium is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 4, 7, 21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3, 11]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 20, 21]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 11]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 6, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 17, 18]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 10]}\n    ],\n    \"complexes\": [\"MT1-MMP:TIMP2:proMMP-2 ternary complex\", \"eHSP90:TIMP2:MMP-2 complex\", \"TIMP-2:MMP-2 complex\"],\n    \"partners\": [\"MMP14\", \"MMP2\", \"HSP90\", \"AHA1\", \"ITGA3\", \"BiP\", \"MARCH7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}